ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Is it Time for Immune Screening for Belatacept-Treated Stable Kidney Transplant Patients for Adjust the Immunosuppression?

    M. C. Rial1, F. Caro2, N. Ambrosi2, D. Guerrieri2, A. Calleri1, E. Chuluyan1, D. Casadei1

    1ITAC, Buenos Aires, Argentina, 2CEFYBO, UBA, Buenos Aires, Argentina

    *Purpose: Belatacept is a co-stimulation blocker for primary maintenance immunosuppression in kidney transplant recipients. The goal of this work was to study the immunological status…
  • 2020 American Transplant Congress

    Polyfunctional Cytokine Secreting Th17 Cells Preferentially Infiltrate Murine Renal Allografts with Acute Rejection and Are Associated with Elevated Th17: Treg Ratio

    R. Dhital1, V. Velazquez1, Q. Zeng2, M. Shimamura1

    1Center for Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, 2Center for Cardiovascular Research, Nationwide Children's Hospital, Columbus, OH

    *Purpose: Our group has shown that renal transplant patients with acute rejection have elevated blood mRNA RORγt: FOXP3 ratio compared to patients with stable graft…
  • 2020 American Transplant Congress

    Human Organ Culture: A Novel Method for Evaluation of Reperfusion Injury in Human Kidney

    J. T. Langford1, C. Edwards1, J. DiRito2, M. Harris1, S. A. Hosgood3, M. L. Nicholson3, J. S. Pober4, D. Haakinson1, G. T. Tietjen1

    1Department of Surgery, Yale School of Medicine, New Haven, CT, 2Department of Biomedical Engineering, Yale University, New Haven, CT, 3Department of Surgery, University of Cambridge, Cambridge, United Kingdom, 4Department of Immunobiology, Yale School of Medicine, New Haven, CT

    *Purpose: Evaluate the ability of human organ culture to assess protein secretion during a model of reperfusion injury.*Methods: Biopsies are obtained from transplanted-declined human kidneys…
  • 2020 American Transplant Congress

    Neonatal Tolerance Induction: Behaviours of Allogeneic Spleen and Bone Marrow Inocula in Neonatal Mice are Largely Determined by the Nature of Their CD8 T Cells

    R. A. Bascom, K. Tao, L. J. West

    University of Alberta, Edmonton, AB, Canada

    *Purpose: Injected adult allo-spleen (SC) and bone marrow cells (BMC) traffic to secondary lymphoid organs, proliferate and spread throughout neonatal mice; allo-SC consistently cause acute…
  • 2020 American Transplant Congress

    Why Donate to a Stranger? Exploring the Major Motivations of 31 Non-Directed (Altruistic) Living Kidney Donors

    A. Maghen1, G. Mendoza1, S. E. Connor1, S. Nassiri1, L. Kwan1, E. L. Wood1, J. Lalezari1, S. Friedman1, S. George2, S. L. Maliski3, J. L. Veale1

    1Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 2Community Health Sciences, UCLA Fielding School of Public Health, Los Angeles, CA, 3Office of the Dean, University of Kansas Medical Center School of Nursing, Kansas City, KS

    *Purpose: With the steady increase in the number of non-directed donors (NDDs) in the U.S. in the past decade, understanding their motivations may help better…
  • 2020 American Transplant Congress

    Enhancing Kidney Allograft Decision Making: An Organ Offer Simulation Study

    J. Mansy1, J. Case1, D. Stewart2, H. McGehee2, K. Lindblad2, R. Schaffer1, J. Fisher1, J. Rice1, S. Kurian1, C. Marsh1

    1Scripps Center for Organ and Cell Transplantation, La Jolla, CA, 2United Network for Organ Sharing Research Department, Richmond, VA

    *Purpose: This study was designed to identify opportunities to improve UNOS organ allocation as well as providers’ decision-making process for cadaveric kidney offers. Using its…
  • 2020 American Transplant Congress

    Serum αKlotho after Living Kidney Donation: A Systematic Review and Meta-Analysis

    W. Cheungpasitporn1, C. Thongprayoon2, N. Leeaphorn3, M. A. Mao4, J. A. Neyra5

    1Nephrology, University of Mississippi Medical Center, Jackson, MS, 2Nephrology and Hypertension, Mayo Clinic, Rochester, MN, 3Renal Transplant Program, University of Missouri-Kansas City School of Medicine/Saint Luke's Health System, Kansas City, MO, 4Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL, 5Nephrology, University of Kentucky, Lexington, KY

    *Purpose: αKlotho (klotho) is a known anti-aging protein that exerts diverse physiological effects. Defect in klotho gene expression in mice can result in a syndrome…
  • 2020 American Transplant Congress

    Reverse Epidemiology and the Obesity Paradox for Patients with Chronic Kidney Disease

    R. A. Choudhury1, D. Yoeli1, H. B. Moore1, H. Yaffe1, G. Hoeltzel2, K. R. Dumon3, N. N. Williams3, P. L. Abt4, K. D. Conzen1, T. L. Nydam1

    1Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, 2Thomas Jefferson University Hospital, Philadelphia, PA, 3University of Pennsylvania Hospital, Philadelphia, PA, 4Department of Surgery- Division of Transplantation Surgery, University of Pennsylvania Hospital, Philadelphia, PA

    *Purpose: Obesity has been associated with both increased progression of chronic kidney disease as well as with a paradoxical improvement in survival among ESRD patients…
  • 2020 American Transplant Congress

    Clazakizumab (Anti-IL-6 Monoclonal) as an Agent to Reduce Donor Specific Hla Antibodies (DSA) and Improve Outcomes in Patients with Chronic & Active Antibody-Mediated Rejection Post-Kidney Transplantation (NCT03380377)

    S. C. Jordan, N. Ammerman, M. Toyoda, S. Ge, E. Huang, A. Peng, S. Sethi, R. Najjar, E. Ortiz, M. Chu, A. De Guzman, I. Kim, K. Lim, J. Choi, A. Vo

    Cedars Sinai Medical Ctr, Los Angeles, CA

    *Purpose: Highly sensitized (HS) patients are at an increased risk for chronic antibody mediated rejection (cABMR) and graft loss due to persistent, deleterious DSA production.…
  • 2020 American Transplant Congress

    Multi- National Survey among Nephrologists & Transplant Surgeons About the Suitability and Acceptance of the Marginal Live Kidney Donors with Sickle Cell Trait

    Z. Arabi1, A. Mateen1, A. Altheaby1, M. Bukhari2, A. Hamad3, S. Kaysi4, E. Elhassan1

    1KAMC, Riyadh, Saudi Arabia, 2Taif University, Taif, Saudi Arabia, 3The Regional Medical Center, Orangeburg, SC, 4CHU Clermont-Ferrand, Saint Pryv/ Saint Mesmin, France

    *Purpose: Due to organ shortage, many transplant centers may consider “marginal” kidney donors as those with sickle cell trait ( SCT) for donation. Acceptance of…
  • « Previous Page
  • 1
  • …
  • 78
  • 79
  • 80
  • 81
  • 82
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences